Identification of skeletal muscle autoantigens by expression library screening using sera from autoimmune rippling muscle disease (ARMD) patients

Journal of Cellular Biochemistry

Volumn 99, Issue 1, 2006, Pages 79-87

  Watkins, Thomas C ^b   Zelinka, Lisa M ^b   Kesic, Matt ^a   Ansevin, Carl F ^a,b   Walker, Gary R ^a,b  

^a YOUNGSTOWN STATE UNIVERSITY   (United States)

^b KENT STATE UNIVERSITY   (United States)

Author keywords

Autoantigen; Mechanosensitive; Rippling muscle disease; Titin like

Indexed keywords

ANTIBODY; ANTISERUM; AUTOANTIGEN; COMPLEMENTARY DNA; CONNECTIN; CONTRACTILE PROTEIN; ISOPROTEIN; MUSCLE ANTIGEN; MUSCLE PROTEIN; NUCLEOTIDE; PHOSPHOPROTEIN PHOSPHATASE 1; PROTEIN PPP1R3; PROTEIN SUBUNIT; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE 6; REGULATOR PROTEIN; TITIN N2A; UNCLASSIFIED DRUG;

ANTIBODY AFFINITY; ARTICLE; AUTOIMMUNE RIPPLING MUSCLE DISEASE; AUTOIMMUNITY; DNA LIBRARY; DNA SCREENING; HUMAN; HUMAN TISSUE; IMMUNOGENICITY; MUSCLE CONTRACTILITY; MUSCLE FIBER CONTRACTION; MYASTHENIA GRAVIS; NEUROMUSCULAR DISEASE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REGULATORY MECHANISM; SEQUENCE ANALYSIS; SERUM; SKELETAL MUSCLE;

AMINO ACID SEQUENCE; AUTOANTIGENS; AUTOIMMUNE DISEASES; HUMANS; IMMUNE SERA; MITOCHONDRIAL PROTON-TRANSLOCATING ATPASES; MOLECULAR SEQUENCE DATA; MUSCLE PROTEINS; MUSCLE, SKELETAL; MUSCULAR DISEASES; MYASTHENIA GRAVIS; PHOSPHOPROTEIN PHOSPHATASE; PROTEIN KINASES; SEQUENCE ANALYSIS, PROTEIN;

EID: 33748079775     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.20857     Document Type: Article

References (36)

1. Alarcon-Segovia D, Ruiz-Arguelles A, Llorente L. 1996. Broken dogma: Penetration of autoantibodies into living cells. Immunol Today 17:163-164.
2. Ansevin CF. 1996. Rippling muscles and myasthenia gravis: A stretch activated channelopathy? Neuromuscul Disord 6(suppl):S6.
3. Ansevin CF, Agamanolis DP. 1996. Rippling muscles and myasthenia gravis with rippling muscles. Arch Neurol 53:197-199.
4. Betz RC, Schoser BGH, Kasper D, Ricker K, Ramirez A, Stein V, Torbergsen T, Lee Y-A, Nothen MM, Wienker TF, Malin J-P, Propping P, Reis A, Mortier W, Jentsch TJ, Vorgerd M, Kubisch C. 2001. Mutations in CAV3 cause mechanical hyperirritability of skeletal muscle in rippling muscle disease. Nat Genet 28:218-219.
5. Bonne G, Carrier L, Richard P, Hainque B, Schwartz K. 1998. Familial hypertrophic cardiomyopathy: From mutations to functional defects. Circ Res 83:580-593.
6. de Paula F, Vainzof M, Bernardino AL, McNally E, Kunkel LM, Zatz M. 2001. Mutations in the caveolin-3 gene: When are they pathogenic? Am J Med Genet 99:303-307.
7. Furukawa T, Ono Y, Tsuchiya H, Katayama Y, Bang ML, Labeit D, Labeit S, Inagaki N, Gregorio CC. 2001. Specific interaction of the potassium channel beta-subunit minK with the sarcomeric protein T-cap suggests a T-tubule-myofibril linking system. J Mol Biol 313:775-784.
8. Gautel M, Lakey A, Barlow DP, Holmes Z, Scales S, Leonard K, Labeit S, Mygland A, Gilhus NE, Aarli JA. 1993. Titin antibodies in myasthenia gravis: Identification of a major immunogenic region of titin. Neurology 43:1581-1585.
9. Gerull B, Gramlich M, Atherton J, McNabb M, Trombitas K, Sasse-Klaassen S, Seidman JG, Seidman C, Granzier H, Labeit S, Frenneaux M, Thierfelder L. 2002. Mutations of TTN, encoding the giant muscle filament titin, cause familial dilated cardiomyopathy. Nat Genet 30:201-204.
10. Gutierrez-Cruz G, Van Heerden AH, Wang K. 2001. Modular motif, structural folds and affinity profiles of PEVK segment of human fetal skeletal muscle titin. J Biol Chem 276:7442-7449.
11. Hackman P, Vihola A, Haravuori H, Marchand S, Sarparanta J, De Seze J, Labeit S, Witt C, Peltonen L, Richard I, Udd B. 2002. Tibial muscular dystrophy is a titinopathy caused by mutations in TTN, the gene encoding the giant skeletal-muscle protein titin. Am J Hum Genet 71:492-500.
12. Hein S, Schaper J. 2002. Weakness of a giant: Mutations of the sarcomeric protein titin. Trends Mol Med 8:311-313.
13. Hoch W, McConville J, Helms S, Newsom-Davis J, Melms A, Vincent A. 2001. Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies. Nat Med 7:365-368.
14. Jusic A. 1989. Hereditary increased muscle mechanical irritability and progressive contracture with stretch-induced electromyographic activity. Muscle Nerve 12:103-107.
15. Kolmerer B, Witt CC, Freiburg A, Millevoi S, Stier G, Sorimachi H, Pelin K, Carrier L, Schwartz K, Labeit D, Gregorio CC, Linke WA, Labeit S. 1999. The titin cDNA sequence and partial genomic sequences: Insights into the molecular genetics, cell biology and physiology of the titin filament system. Rev Physiol Biochem Pharmacol 138:19-55.
16. Koul RL, Chand RP, Chacko A, Ali M, Brown KM, Bushnarmuth SR, Escolar DM, Stephan DA. 2001. Severe autosomal recessive rippling muscle disease. Muscle Nerve 24:1542-1547.
17. Labeit S, Kolmerer B. 1995. Titins: Giant proteins in charge of muscle ultrastructure and elasticity. Science 270:293-296.
18. Lübke E, Freiburg A, Skeie GO, Kolmerer B, Labeit S, Aarli JA, Gilhus NE, Wollmann R, Wussling M, Rüegg JC, Linke WA. 1998. Striational autoantibodies in myasthenia gravis patients recognize I-band titin epitopes. J Neuroimmunol 81:98-108.
19. Ma JA, Chapman GV, Chen SL, Penny R, Breit SN. 1987. Flow cytometry with crystal violet to detect intracytoplasmic fluorescence in viable human lymphocytes. Demonstration of antibody entering living cells. J Immunol Methods 104:195-200.
20. Minetti C, Sotgia F, Bruno C, Scartezzini P, Broda P, Bado M, Masetti E, Mazzocco M, Egeo AA, Donati MA, Volonte D, Galbiati F, Cordone G, Bricarelli FD, Lisanti MP, Zara F. 1998. Mutations in the caveolin-3 gene cause autosomal dominant limb-girdle muscular dystrophy. Nat Genet 18:365-368.
21. Muller-Felber W, Ansevin CF, Ricker K, Muller-Jenssen A, Topfer M, Goebel HH, Pongratz DE. 1999. Immunosuppression treatment of rippling muscles in patients with myasthenia gravis. Neuromuscul Disord 9:604-607.
22. Ricker K, Moxley RT, Rohkamm R. 1989. Rippling muscle disease. Arch Neurol 46:405-408.
23. Satoh M, Takahashi M, Sakamoto T, Hiroe M, Marumo F, Kimura A. 1999. Structural analysis of the titin gene in hypertrophic cardiomyopathy: Identification of a novel disease gene. Biochem Biophys Res Commun 262:411-417.
24. Skeie GO. 2000. Skeletal muscle titin: Physiology and pathophysiology. Cell Mol Life Sci 57:1570-1576.
25. Sotgia F, Minetti C, Lisanti MP. 1999. Localization of the human caveolin-3 gene t the D3S18/D3S4163/D3S4539 locus (3p25), in close proximity to the human oxytocin receptor gene. FEBS Lett 452:177-180.
26. Stephan D, Hoffman E. 1999. Physical mapping of the rippling muscle disease locus. Genomics 55:268-274.
27. Stephan DA, Buist NRM, Chittenden AB, Ricker K, Zhou J, Hoffman EP. 1994. A rippling muscle disease gene is localized to 1q41: Evidence for multiple genes. Neurology 44:1915-1920.
28. Tatsumi R, Maeda K, Hattori A, Takahashi K. 2001. Calcium binding to an elastic portion of connectin/titin filaments. J Muscle Res Cell Motil 22:149-162.
29. Torbergsen T. 1975. A family with dominant hereditary myotonia, muscular hypertrophy and increased muscular irritability, distinct from myotonia congenita Thomson. Acta Neurology Scand 51:225-232.
30. Trinick J. 1992. Understanding the functions of titin and nebulin. FEBS Lett 307(1):44-48.
31. Udd B, Haravuori H, Kalimo H, Partanen J, Pulkkinen L, Paetau A, Peltonen L, Somer H. 1998. Tibial muscular dystrophy-From clinical description to linkage on chromosome 2q31. Neuromuscul Disord 8:327-332.
32. Vincent A, Palace J, Hilton-Jones D. 2001. Myasthenia gravis. Lancet 357:2122-2128.
33. Vorgerd M, Ricker K, Ziemssen F, Kress W, Goebel HH, Nix WA, Kubisch C, Schoser BGH, Mortier W. 2001. A sporadic case of rippling muscle disease caused by a de novo caveolin-3 mutation. Neurology 57:2273-2277.
34. Walker G, Watkins T, Raab S, Ansevin C. 1998. Antibodies identified in autoimmune rippling muscle disease associated with myasthenia gravis. Mol Biol Cell 9(suppl):27a.
35. Walker GR, Watkins T, Ansevin CF. 1999. Identification of autoantibodies associated with rippling muscles and myasthenia gravis that recognize skeletal muscle proteins: Possible relationship of antigens and stretch-activated ion channels. Biochem Biophy Res Comm 264:430-435.
36. Wang SM, Greaser ML. 1985. Immunocytochemical studies using a monoclonal antibody to bovine cardiac titin on intact and extracted myofibrils. J Muscle Res Cell Motil 6:293-312.